Prognostic factors in first-line atezolizumab-bevacizumab treatment of intermediate or advanced hepatocellular carcinoma
Kyowon Gu, Tae Wook Kang, Jaeseung Shin, Dong Hyun Sinn, Myung Ji Goh, Jung Yong Hong, Sangah Chi · 2026
Read Prognostic factors in first-line atezolizumab-bevacizumab treatment of intermediate or advanced hepatocellular carcinoma by Kyowon Gu, Tae Wook Kang, Jaeseung Shin, Dong Hyun Sinn, Myung Ji Goh, Jung Yong Hong, Sangah Chi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0354176.txt.
Description
Kyowon Gu and six colleagues published this 2026 study of forty-seven patients with intermediate or advanced liver cancer starting a combined modern immunotherapy and blood-vessel-blocking treatment. Using records and pre-treatment MRI scans from a Korean center, they searched for traits predicting how long the cancer stayed controlled.
Tumors spanning ten centimeters or more, and a bright rim pattern on scans, predicted earlier progression. Younger age and added radiotherapy also entered the picture in linked ways. Gu's findings may help clinicians doctors judge who needs closer watching or different first treatment.
Catalog record
| CREATOR | Kyowon Gu, Tae Wook Kang, Jaeseung Shin, Dong Hyun Sinn, Myung Ji Goh, Jung Yong Hong, Sangah Chi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36014 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |